510(k) K023712

ADVANTAGE MULTIPLE DRUGS OF ABUSE TEST by Advantage Diagnostics Corp. — Product Code DKZ

K023712 is an FDA 510(k) premarket notification submitted by Advantage Diagnostics Corp. for the device "ADVANTAGE MULTIPLE DRUGS OF ABUSE TEST". The FDA issued a decision of Substantially Equivalent on January 31, 2003. The device falls under product code DKZ (Enzyme Immunoassay, Amphetamine), a Class II device regulated under 21 CFR 862.3100. Advantage Diagnostics Corp. has at least 9 other 510(k) clearances on record.